QQQ   388.74 (+0.37%)
AAPL   193.02 (-0.21%)
MSFT   371.83 (-0.19%)
META   320.33 (+0.64%)
GOOGL   131.28 (+0.22%)
AMZN   146.13 (-0.51%)
TSLA   245.38 (+2.79%)
NVDA   467.00 (+0.29%)
NIO   7.89 (+6.19%)
BABA   72.28 (-0.14%)
AMD   120.44 (+1.74%)
T   17.17 (-0.29%)
F   10.78 (+1.70%)
MU   74.33 (+0.87%)
CGC   0.70 (+4.70%)
GE   121.93 (+1.41%)
DIS   90.69 (-0.11%)
AMC   7.07 (+0.71%)
PFE   29.14 (+0.17%)
PYPL   58.89 (+1.67%)
XOM   100.08 (-0.36%)
QQQ   388.74 (+0.37%)
AAPL   193.02 (-0.21%)
MSFT   371.83 (-0.19%)
META   320.33 (+0.64%)
GOOGL   131.28 (+0.22%)
AMZN   146.13 (-0.51%)
TSLA   245.38 (+2.79%)
NVDA   467.00 (+0.29%)
NIO   7.89 (+6.19%)
BABA   72.28 (-0.14%)
AMD   120.44 (+1.74%)
T   17.17 (-0.29%)
F   10.78 (+1.70%)
MU   74.33 (+0.87%)
CGC   0.70 (+4.70%)
GE   121.93 (+1.41%)
DIS   90.69 (-0.11%)
AMC   7.07 (+0.71%)
PFE   29.14 (+0.17%)
PYPL   58.89 (+1.67%)
XOM   100.08 (-0.36%)
QQQ   388.74 (+0.37%)
AAPL   193.02 (-0.21%)
MSFT   371.83 (-0.19%)
META   320.33 (+0.64%)
GOOGL   131.28 (+0.22%)
AMZN   146.13 (-0.51%)
TSLA   245.38 (+2.79%)
NVDA   467.00 (+0.29%)
NIO   7.89 (+6.19%)
BABA   72.28 (-0.14%)
AMD   120.44 (+1.74%)
T   17.17 (-0.29%)
F   10.78 (+1.70%)
MU   74.33 (+0.87%)
CGC   0.70 (+4.70%)
GE   121.93 (+1.41%)
DIS   90.69 (-0.11%)
AMC   7.07 (+0.71%)
PFE   29.14 (+0.17%)
PYPL   58.89 (+1.67%)
XOM   100.08 (-0.36%)
QQQ   388.74 (+0.37%)
AAPL   193.02 (-0.21%)
MSFT   371.83 (-0.19%)
META   320.33 (+0.64%)
GOOGL   131.28 (+0.22%)
AMZN   146.13 (-0.51%)
TSLA   245.38 (+2.79%)
NVDA   467.00 (+0.29%)
NIO   7.89 (+6.19%)
BABA   72.28 (-0.14%)
AMD   120.44 (+1.74%)
T   17.17 (-0.29%)
F   10.78 (+1.70%)
MU   74.33 (+0.87%)
CGC   0.70 (+4.70%)
GE   121.93 (+1.41%)
DIS   90.69 (-0.11%)
AMC   7.07 (+0.71%)
PFE   29.14 (+0.17%)
PYPL   58.89 (+1.67%)
XOM   100.08 (-0.36%)

Cizzle Biotechnology Share Price, News & Analysis (LON:CIZ)

GBX 2.38
+0.01 (+0.42%)
(As of 02:19 PM ET)
Today's Range
2.36
2.56
50-Day Range
1.71
2.50
52-Week Range
1.36
4.84
Volume
2.08 million shs
Average Volume
3.51 million shs
Market Capitalization
£8.68 million
Assets Under Management
£48.98 million
Dividend Yield
3.31%
Net Expense Ratio
0.46%
CIZ stock logo

About Cizzle Biotechnology (LON:CIZ)

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

CIZ Stock Price History

CIZ ETF News Headlines

Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
Philadelphia Biotech News
Cizzle Biotechnology Holdings PLC (CIZ)
Lithium Discovery So BIG You Can't Miss it, Even From Space
With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!
EFA ETF Volatility (VXEFA)
See More Headlines
Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Victory Capital Management
Fund Name
VictoryShares Developed Enhanced Volatility Wtd ETF
Tax Classification
Regulated Investment Company
Inception Date
9/30/2014
Fund Manager
Mannik Dhillon, Stephen Hammers
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
Global Ex-U.S.
Number of Holdings
505

Fund Statistics

Assets Under Management
$48.98 million
Average Daily Volume
$9,243.20
Discount/Premium
0.17%

Administrator, Advisor and Custodian

Administrator
Victory Capital Management Inc.
Advisor
Victory Capital Management Inc.
Custodian
Citibank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
N/A
Short Interest
15,600 shs

Miscellaneous

Beta
0.13
Creation Unit
50,000
Creation Fee
$4,500.00
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Cizzle Biotechnology Expenses

TypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFs
Management Fee0.40%0.56%0.53%0.45%0.51%
Other Expenses0.25%0.30%0.53%0.25%0.57%
Total Expense0.66%0.63%0.69%0.54%0.69%
Fee Waiver-0.20%-0.20%-0.54%-0.20%-0.58%
Net Expense0.46%0.60%0.59%0.47%0.57%

Cizzle Biotechnology (CIZ) Holdings & Exposure

Top 10 CIZ Holdings

  • Federated Hermes Treasury Obl IS
    Holding Weight: 75.19%
  • Mini Msci Eafe Fut Dec23
    Holding Weight: 0.47%
  • Murata Manufacturing Co Ltd
    Holding Weight: 0.15%
  • Futures Collateral - Cash
    Holding Weight: 0.13%
  • Honda Motor Co Ltd
    Holding Weight: 0.13%
  • Keyence Corp
    Holding Weight: 0.12%
  • SoftBank Corp
    Holding Weight: 0.12%
  • BCE(NYSE:BCE)
    Holding Weight: 0.09%
  • (GWO)(NYSEARCA:GWO)
    Holding Weight: 0.09%
  • Koninklijke KPN NV
    Holding Weight: 0.09%

CIZ Sector Exposure

CIZ Industry Exposure

Key Executives

  • Mr. Allan John Syms (Age 66)
    Executive Chairman
  • Prof. Dawn Coverley (Age 57)
    Founder, Chief Scientific Officer & Non-Executive Director
  • Mr. Nigel R. Lee (Age 61)
    Finance Director & Executive Director
  • Mr. Morgan Williams
    Head of Commercialisation for Yorkshire Cancer Research and Board Observer














CIZ ETF - Frequently Asked Questions

How have CIZ shares performed in 2023?

Cizzle Biotechnology's stock was trading at GBX 1.45 at the start of the year. Since then, CIZ stock has increased by 64.5% and is now trading at GBX 2.39.
View the best growth stocks for 2023 here
.

How often does Cizzle Biotechnology pay dividends? What is the dividend yield for Cizzle Biotechnology?

Cizzle Biotechnology announced a monthly dividend on Tuesday, May 9th. Stockholders of record on Thursday, May 11th will be given a dividend of GBX 0.09 per share on Friday, May 12th. This represents a $1.08 dividend on an annualized basis and a yield of 45.28%. The ex-dividend date of this dividend is Wednesday, May 10th.
Read our dividend analysis for CIZ
.

What does CIZ invest in?

Cizzle Biotechnology is a equity fund issued by Victory Capital Management. CIZ focuses on large cap investments and follows the Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index. The fund's investments total to approximately $48.98 million assets under management.

What stocks does Cizzle Biotechnology hold?
What is the management fee for Cizzle Biotechnology?

Cizzle Biotechnology's management fee is 0.40% and has other expenses of 0.25%. However, CIZ has a fee waiver of -0.20% to reimburse the expenses. The net expense ratio for CIZ is 0.46%.

How do I buy shares of Cizzle Biotechnology?

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CIZ) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -